Genetic association between helpless trait and depression-related phenotypes: Evidence from crossbreeding studies with H/Rouen and NH/Rouen mice

International Journal of Neuropsychopharmacology

Volumn 15, Issue 3, 2012, Pages 363-374

  Yacoubi, Malika El ^a,b   Popa, Daniela ^c,d   Martin, Benoît ^c,e   Zimmer, Luc ^b,g   Hamon, Michel ^c,d   Adrien, Joëlle ^c,d   Vaugeois, Jean Marie ^a,b,f  

^a LYON NEUROSCIENCE RESEARCH CENTER   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITÉ DE RENNES 1   (France)

^f UNIVERSITÉ DE ROUEN   (France)

^g HOSPICES CIVILS DE LYON   (France)

Author keywords

Crossbreeding; depressive disorder; mouse model; sleep; tail suspension test

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SUCROSE; SUGAR INTAKE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS BREEDING; DEPRESSION; DRUG SCREENING; FEMALE; FORCED SWIMMING TEST; GENE SEGREGATION; GENETIC ASSOCIATION; HELPLESSNESS; IMMOBILIZATION STRESS; LOCOMOTION; MAJOR DEPRESSION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SLEEP PATTERN; TREATMENT RESPONSE; ADMINISTRATION AND DOSAGE; ANHEDONIA; ANIMAL; DEPRESSIVE DISORDER; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; INBRED MOUSE STRAIN; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PERSONALITY; PHYSIOLOGY; SLEEP; SPECIES DIFFERENCE; SUGAR INTAKE;

ANHEDONIA; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; FEMALE; FLUOXETINE; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PERSONALITY; PHENOTYPE; SLEEP; SPECIES SPECIFICITY;

EID: 80054104520     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000605     Document Type: Article

References (48)

1. Adrien J, Dugovic C, Martin P (1991). Sleep-wakefulness patterns in the helpless rat. Physiology and Behavior 49, 257-262.
2. Bai F, Li X, Clay M, Lindstrom T, et al. (2001). Intra-and interstrain differences in models of 'behavioral despair'. Pharmacology, Biochemistry and Behavior 70, 187-192. (Pubitemid 33049928)
3. Benca R (2000). Mood disorders. In : Kryger MRT, Dement W (Eds), Principles and Practice of Sleep Medicine (pp. 1140-1158). Philadelphia : Saunders.
4. Bourin M, Chenu F, Ripoll N, David DJ (2005). A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behavioural Brain Research 164, 266-269. (Pubitemid 41337881)
5. Cryan JF, Holmes A (2005). The ascent of mouse: Advances in modelling human depression and anxiety. Nature Reviews Drug Discovery 4, 775-790. (Pubitemid 43090498)
6. Cryan JF, Mombereau C, Vassout A (2005). The tail suspension test as a model for assessing antidepressant activity : review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews 29, 571-625. (Pubitemid 40755457)
7. Dugovic C, Maccari S, Weibel L, Turek FW, et al. (1999). High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. Journal of Neuroscience 19, 8656-8664. (Pubitemid 30226784)
8. Duman CH, Schlesinger L, Kodama M, Russell DS, et al. (2007). A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biological Psychiatry 61, 661-670. (Pubitemid 46328865)
9. El Yacoubi M, Bouali S, Popa D, Naudon L, et al. (2003). Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proceedings of the National Academy of Sciences USA 100, 6227-6232. (Pubitemid 36576958)
10. El Yacoubi M, Ledent C, Menard JF, Parmentier M, et al. (2000). The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. British Journal of Pharmacology 129, 1465-1473. (Pubitemid 30175720)
11. El Yacoubi M, Vaugeois JM (2007). Genetic rodent models of depression. Current Opinion in Pharmacology 7, 3-7. (Pubitemid 46238040)
12. El Yacoubi M, Vaugeois JM, Marguet D, Sauze N, et al. (2006). Behavioral characterization of CD26 deficient mice in animal tests of anxiety and antidepressant-like activity. Behavioural Brain Research 171, 279-285. (Pubitemid 43964863)
13. Fava M, Kendler KS (2000). Major depressive disorder. Neuron 28, 335-341.
14. Franken P, Malafosse A, Tafti M (1998). Genetic variation in EEG activity during sleep in inbred mice. American Journal of Physiology 275, R1127-R1137.
15. Fukui M, Rodriguiz RM, Zhou J, Jiang SX, et al. (2007). Vmat2 heterozygous mutant mice display a depressivelike phenotype. Journal of Neuroscience 27, 10520-10529. (Pubitemid 47502010)
16. Gurevich I, Tamir H, Arango V, Dwork AJ, et al. (2002). Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34, 349-356. (Pubitemid 34465494)
17. Henderson ND (1997). Spurious associations in unreplicated selected lines. Behavior Genetics 27, 145-154. (Pubitemid 27203930)
18. Insel TR, Charney DS (2003). Research on major depression: strategies and priorities. Journal of the American Medical Association 289, 3167-3168. (Pubitemid 37432893)
19. Kendler KS, Neale MC, Kessler RC, Heath AC, et al. (1994). The clinical characteristics of major depression as indices of the familial risk to illness. British Journal of Psychiatry 165, 66-72. (Pubitemid 24224838)
20. Kupfer DJ (1976). REM latency : A psychobiologic marker for primary depressive disease. Biological Psychiatry 11, 159-174.
21. Lemonde S, Du L, Bakish D, Hrdina P, et al. (2004). Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. International Journal of Neuropsychopharmacology 7, 501-506. (Pubitemid 39648081)
22. Lena C, Popa D, Grailhe R, Escourrou P, et al. (2004). Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice. Journal of Neuroscience 24, 5711-5718. (Pubitemid 38857225)
23. Levinson DF (2006). The genetics of depression: A review. Biological Psychiatry 60, 84-92.
24. Liu X, Gershenfeld HK (2001). Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice. Biological Psychiatry 49, 575-581. (Pubitemid 32289351)
25. Lustberg L, Reynolds CF (2000). Depression and insomnia: questions of cause and effect. Sleep Medicine Reviews 4, 253-262. (Pubitemid 30416008)
26. Maudhuit C, Prevot E, Dangoumau L, Martin P, et al. (1997). Antidepressant treatment in helpless rats : effect on the electrophysiological activity of raphe dorsalis serotonergic neurons. Psychopharmacology 130, 269-275. (Pubitemid 27170360)
27. Naidu PS, Varvel SA, Ahn K, Cravatt BF, et al. (2007). Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Psychopharmacology 192, 61-70. (Pubitemid 46673891)
28. Overstreet DH (2002). Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behavior Genetics 32, 335-348. (Pubitemid 35192994)
29. Parsey RV, Olvet DM, Oquendo MA, Huang YY, et al. (2006). Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31, 1745-1749. (Pubitemid 44106705)
30. Popa D, El Yacoubi M, Vaugeois JM, Hamon M, et al. (2006). Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5-HT1A receptor activation. Neuropsychopharmacology 31, 1637-1646. (Pubitemid 44106695)
31. Popa D, Lena C, Alexandre C, Adrien J (2008). Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development : evidence from sleep, stress, and behavior. Journal of Neuroscience 28, 3546-3554.
32. Popa D, Lena C, Fabre V, Prenat C, et al. (2005). Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. Journal of Neuroscience 25, 11231-11238. (Pubitemid 43083697)
33. Porsolt RD, Le Pichon M, JalfreM(1977). Depression: A new animal model sensitive to antidepressant treatments. Nature 266, 730-732. (Pubitemid 8073804)
34. Porsolt RD, Lenègre A (1992). Behavioral models of depression. In : Elliott J, Heal DJ, Marsden CA (Eds), Experimental Approaches to Anxiety and Depression (pp. 73-85). London: Wiley.
35. Rausch JL, Johnson ME, Kasik KE, Stahl SM (2006). Temperature regulation in depression: functional 5HT1A receptor adaptation differentiates antidepressant response. Neuropsychopharmacology 31, 2274-2280. (Pubitemid 44413207)
36. Ripoll N, David DJ, Dailly E, Hascoet M, et al. (2003). Antidepressant-like effects in various mice strains in the tail suspension test. Behavioural Brain Research 143, 193-200. (Pubitemid 36937164)
37. Sham PC, Sterne A, Purcell S, Cherny S, et al. (2000). GENESiS: creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings. Twin Research 3, 316-322. (Pubitemid 32126935)
38. Steru L, Chermat R, Thierry B, Mico JA, et al. (1987). The automated Tail Suspension Test : A computerized device which differentiates psychotropic drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry 11, 659-671. (Pubitemid 18004312)
39. Strekalova T, Spanagel R, Bartsch D, Henn FA, et al. (2004). Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 29, 2007-2017. (Pubitemid 39486552)
40. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry 157, 1552-1562.
41. Svenningsson P, Chergui K, Rachleff I, Flajolet M, et al. (2006). Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311, 77-80. (Pubitemid 43063061)
42. Trullas R, Jackson B, Skolnick P (1989). Genetic differences in a tail suspension test for evaluating antidepressant activity. Psychopharmacology 99, 287-288. (Pubitemid 19215234)
43. Turri MG, Datta SR, DeFries J, Henderson ND, et al. (2001). QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice. Current Biology 11, 725-734. (Pubitemid 32442789)
44. van der Heyden JA, Molewijk E, Olivier B (1987). Strain differences in response to drugs in the tail suspension test for antidepressant activity. Psychopharmacology 92, 127-130. (Pubitemid 17063676)
45. Vaugeois JM, Passera G, Zuccaro F, Costentin J (1997). Individual differences in response to imipramine in the mouse tail suspension test. Psychopharmacology 134, 387-391. (Pubitemid 28023413)
46. Willner P (1990). Animal models of depression: An overview. Pharmacology and Therapeutics 45, 425-455. (Pubitemid 20003442)
47. Willner P (1997). Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology 134, 319-329. (Pubitemid 28023396)
48. Yoshikawa T, Watanabe A, Ishitsuka Y, Nakaya A, et al. (2002). Identification of multiple genetic loci linked to the propensity for 'behavioral despair' in mice. Genome Research 12, 357-366. (Pubitemid 34233010)